Mankind Pharma Limited has informed the Exchange about Incorporation
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has incorporated a wholly owned subsidiary named 'Mankind Pharma Lanka (Private) Limited' in Sri Lanka on July 23, 2025. This follows an earlier intimation dated May 21, 2025. The subsidiary is fully owned by Mankind Pharma with no external investors. This move is likely aimed at expanding the company's international footprint into the South Asian market.
This is a routine corporate action signalling Mankind Pharma's international expansion plans, but it is unlikely to have an immediate material impact on the stock price or existing shareholders. The subsidiary is fully owned, so there is no equity dilution.